Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Drug interactions with rivaroxaban following total joint replacement surgery.

Kwong LM, Tong LM.

Ann Pharmacother. 2012 Sep;46(9):1232-8. doi: 10.1345/aph.1R055. Epub 2012 Aug 28. Review.

PMID:
22932305
[PubMed - indexed for MEDLINE]
2.

Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.

Stevenson M, Scope A, Holmes M, Rees A, Kaltenthaler E.

Health Technol Assess. 2009 Oct;13 Suppl 3:43-8. doi: 10.3310/hta13suppl3/07. Review.

PMID:
19846028
[PubMed - indexed for MEDLINE]
Free Article
3.

Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.

Duggan ST.

Am J Cardiovasc Drugs. 2012 Feb 1;12(1):57-72. doi: 10.2165/11208470-000000000-00000. Review.

PMID:
22272729
[PubMed - indexed for MEDLINE]
4.

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data.

Kwong LM.

Vasc Health Risk Manag. 2011;7:461-6. doi: 10.2147/VHRM.S4441. Epub 2011 Jul 18. Review.

PMID:
21822393
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.

Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M.

Pharmacoeconomics. 2012 Feb 1;30(2):87-101. doi: 10.2165/11599370-000000000-00000.

PMID:
22187932
[PubMed - indexed for MEDLINE]
6.

Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.

Kwong LM.

Am J Manag Care. 2011 Feb;17(1 Suppl):S22-6. Review.

PMID:
21517652
[PubMed - indexed for MEDLINE]
Free Article
7.

The role of apixaban for venous and arterial thromboembolic disease.

Prom R, Spinler SA.

Ann Pharmacother. 2011 Oct;45(10):1262-83. doi: 10.1345/aph.1Q119. Epub 2011 Sep 27. Review.

PMID:
21954450
[PubMed - indexed for MEDLINE]
8.

Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.

Ageno W.

Expert Rev Cardiovasc Ther. 2009 Jun;7(6):569-76. doi: 10.1586/erc.09.37.

PMID:
19505271
[PubMed - indexed for MEDLINE]
9.

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.

Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG.

Thromb Haemost. 2007 Jun;97(6):931-7.

PMID:
17549294
[PubMed - indexed for MEDLINE]
10.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG; RECORD3 Investigators.

N Engl J Med. 2008 Jun 26;358(26):2776-86. doi: 10.1056/NEJMoa076016.

PMID:
18579812
[PubMed - indexed for MEDLINE]
Free Article
11.

Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.

Eriksson BI, Rosencher N, Friedman RJ, Homering M, Dahl OE.

Thromb Res. 2012 Aug;130(2):147-51. doi: 10.1016/j.thromres.2011.12.005. Epub 2012 Jan 5.

PMID:
22225858
[PubMed - indexed for MEDLINE]
12.

A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.

McCullagh L, Tilson L, Walsh C, Barry M.

Pharmacoeconomics. 2009;27(10):829-46. doi: 10.2165/11313800-000000000-00000.

PMID:
19803538
[PubMed - indexed for MEDLINE]
13.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group.

N Engl J Med. 2008 Jun 26;358(26):2765-75. doi: 10.1056/NEJMoa0800374.

PMID:
18579811
[PubMed - indexed for MEDLINE]
Free Article
14.

Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.

Duggan ST, Scott LJ, Plosker GL.

Drugs. 2009;69(13):1829-51. doi: 10.2165/11200890-000000000-00000. Review.

PMID:
19719335
[PubMed - indexed for MEDLINE]
15.

Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.

Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M.

J Med Econ. 2011;14(6):824-34. doi: 10.3111/13696998.2011.623203. Epub 2011 Oct 24.

PMID:
22023098
[PubMed - indexed for MEDLINE]
16.

Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.

Mueck W, Eriksson BI, Bauer KA, Borris L, Dahl OE, Fisher WD, Gent M, Haas S, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG.

Clin Pharmacokinet. 2008;47(3):203-16.

PMID:
18307374
[PubMed - indexed for MEDLINE]
17.

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.

Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Muehlhofer E, Dierig C, Misselwitz F, Kälebo P; ODIXa-HIP Study Investigators.

Circulation. 2006 Nov 28;114(22):2374-81. Epub 2006 Nov 20.

PMID:
17116766
[PubMed - indexed for MEDLINE]
Free Article
18.

Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective.

McDonald H, Diamantopoulos A, Wells P, Lees M, Folkerts K, Forster F, Ananthapavan J.

J Med Econ. 2012;15(5):817-28. doi: 10.3111/13696998.2012.684116. Epub 2012 Apr 24.

PMID:
22494267
[PubMed - indexed for MEDLINE]
19.

Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: the Safe, Simple Transitions (SST) study.

Mills RM, Berkowitz RD, Damaraju CV, Jennings LK, Wildgoose P.

Thromb Res. 2012 Nov;130(5):709-15. doi: 10.1016/j.thromres.2012.07.014. Epub 2012 Aug 2.

PMID:
22857800
[PubMed - indexed for MEDLINE]
20.

Cost-effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden.

Ryttberg L, Diamantopoulos A, Forster F, Lees M, Fraschke A, Björholt I.

Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):601-15. doi: 10.1586/erp.11.65.

PMID:
21958104
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk